TGFB1 and neoplasm: TGF-β1 induces the expression of immune checkpoints such as programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA4) on T cells, thereby attenuating T cell-mediated anti-tumor immune surveillance [26,27].